SLB Limited filings document the regulatory record of a Curaçao-based operating company with common stock listed on the New York Stock Exchange under the symbol SLB. Its Form 8-K disclosures furnish quarterly earnings releases, Regulation FD operational updates, and financial information related to business performance and completed acquisition activity.
SLB proxy and governance filings cover annual meeting voting results, director elections, advisory executive compensation matters, financial statement and dividend approvals, auditor ratification, board composition, and committee assignments. Other current reports disclose director appointments or resignations, capital-market security information, and operational updates that affect reported outlook and risk disclosure.
SLB Limited, through subsidiary Schlumberger Investment S.A., issued three tranches of unsecured senior notes under an existing shelf registration. The Issuer sold $500,000,000 of 4.550% Senior Notes due 2031, $500,000,000 of 4.800% Senior Notes due 2033, and $1,000,000,000 of 5.150% Senior Notes due 2036, all fully and unconditionally guaranteed by SLB Limited. The notes were issued under an existing indenture structure, as supplemented on May 7, 2026, and placed with underwriters led by J.P. Morgan Securities LLC, HSBC Securities (USA) Inc. and Standard Chartered Bank.
SLB LIMITED/NV director Patrick de La Chevardiere executed an open-market sale of company stock. On this transaction date, he sold 2,000 shares of common stock at a price of $54.33 per share. After the sale, he directly owned 16,953 shares of SLB common stock.
SLB director reported proposed security dispositions under Form 144. The filing lists two proposed sales by Patrick de La Chevardiere of 2,000 shares on 03/25/2026 and 2,000 shares on 03/26/2026, each paired with a numeric value shown as $104,200.00 and $103,900.00. The record also shows a Director Stock Grant of 7,024 shares dated 05/03/2021. Exchange is listed as NYSE.
SLB LIMITED/NV executive Steve Matthew Gassen, EVP, Geographies, reported combined option exercises and share sales in SLB common stock. He exercised non-qualified stock options for 21,980 shares at $38.75 and 11,399 shares at $41.47 per share, converting these into common stock.
On the same date, he executed open-market sales totaling 53,379 shares at weighted average prices of $56.19 and $56.16 per share, with trade prices ranging from $56.01 to $56.45 and from $56.13 to $56.235. Following these transactions, he holds 47,421 shares directly and 5,739 equivalent shares indirectly through the SLB Stock Fund.
Galuccio Miguel Matias reported acquisition or exercise transactions in this Form 4 filing.
SLB LIMITED/NV director Miguel Matias Galuccio received a stock award of 3,428 shares of common stock. The award was granted at no cash cost per share pursuant to the SLB 2004 Stock and Deferral Plan for Non-Employee Directors. After this grant, he directly holds 51,653 shares.
SLB LIMITED/NV director Maria Moraeus Hanssen reported receiving a grant of 3,428 shares of common stock. The shares were acquired at a stated price of $0.00 per share, indicating an equity award rather than an open-market purchase.
After this grant, she directly holds 35,016 shares of SLB common stock. The award was made pursuant to the SLB 2004 Stock and Deferral Plan for Non-Employee Directors, reflecting standard director compensation in stock.
Sheets Jeffrey Wayne reported acquisition or exercise transactions in this Form 4 filing.
SLB LIMITED/NV director Jeffrey Wayne Sheets received a grant of 3,428 shares of common stock as compensation. The shares were awarded on May 1, 2026 under the SLB 2004 Stock and Deferral Plan for Non-Employee Directors at no cash cost to him. Following this award, he directly holds 42,453 shares of SLB common stock, reflecting a routine equity-based compensation grant to a non-employee director.
de La Chevardiere Patrick reported acquisition or exercise transactions in this Form 4 filing.
SLB LIMITED/NV director Patrick de La Chevardiere received a stock award of 3,428 common shares. The award was granted at no cash cost per share and was made pursuant to the SLB 2004 Stock and Deferral Plan for Non-Employee Directors. Following this grant, he directly holds 18,953 shares of SLB common stock.
Coleman Peter John reported acquisition or exercise transactions in this Form 4 filing.
SLB LIMITED/NV director Peter John Coleman received a grant of 3,428 shares of common stock as an equity award. The award was made on May 1, 2026 under the SLB 2004 Stock and Deferral Plan for Non-Employee Directors and was priced at $0.00 per share, reflecting compensation rather than an open-market purchase. Following this grant, Coleman directly holds 22,099 shares of SLB common stock.